A61K2035/115

Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology

A method for treating autoimmune and/or inflammatory disease includes a step of identifying a subject exhibiting symptoms of autoimmune and/or inflammatory disease administering a fasting mimicking diet. A probiotic composition for gastrointestinal autoimmune and/or inflammatory disease Bacteroides acidifaciens, Bifidobacterium choerinum, and combinations thereof is also provided.

Application of a bile acid composite bacterial agent in the preparation of feed additives for mutton sheep

The present invention discloses application of a bile acid composite bacterial agent in the preparation of feed additives for mutton sheep. The bile acid composite bacterial agent comprises Parabacteroides distasonis bacterial suspension and bile acid, and the Parabacteroides distasonis bacterial suspension is obtained by cultivation and fermentation of Parabacteroides distasonis LCG-06 with the deposit number CGMCC No. 20820. The bile acid composite bacterial agent of the present invention has natural components and has no toxic and side effects, and can significantly increase the growth rate of mutton sheep and promote nutrition absorption, accelerate the decomposition of in vivo fat of mutton sheep, thereby reducing the body fat percentage of mutton sheep, increasing the slaughter weight and slaughter rate of mutton sheep, increasing the incomes for breeding of mutton sheep. Therefore, it has broad application prospects.

Therapeutic Methods Using Bacterial Strains Which are Capable of Increasing Adenosine Levels
20230057324 · 2023-02-23 · ·

The present invention relates to lactic acid bacterial strains which are capable of producing or inducing the production of adenosine, for use in the production of adenosine in a subject. Therapeutic uses of such strains include the treatment or prevention of diseases associated with adenosine deficiency, for example wound healing. Novel strains are also provided.

CANNABIDIOL-ENHANCED PROBIOTIC COMPOSITIONS AND USES THEREOF FOR TREATMENT OF INFECTIONS
20220362312 · 2022-11-17 ·

Provided is a pharmaceutical composition for treating a microbial imbalance, the composition comprising a pharmaceutically effective amount of at least one strain of probiotic bacteria, a pharmaceutically effective amount of cannabidiol and a pharmaceutically acceptable excipient. Further provided are feminine hygiene products comprising the composition and methods of use of the composition.

Methods and compositions for treatment of microbiome-associated disorders

Disclosed herein are methods and compositions for treatment of a microbiome associated disorder. Further, disclosed herein are methods and compositions for modulating short chain fatty acid production in a subject.

Growth-stimulating Lactobacillus strains

The present invention concerns novel Lactobacillus plantarum strains capable of promoting the growth of a subject, and more particularly the juvenile or prenatal growth of farm animals, and their uses as probiotics.

Composition for improving skin conditions

An object of the present invention is to provide a novel food material effective for improving skin conditions. The present invention provides a composition for use in improving skin conditions, comprising a Lactococcus bacterium as an active ingredient. Examples of the Lactococcus bacterium include Lactococcus lactis. The skin conditions are skin conditions deteriorated by light exposure, such as an increase in skin redness and a decrease in skin moisture content.

COMPOSITIONS BASED ON BACTERIAL STRAINS AND THEIR USE AS ANTI-INFLAMMATORIES
20220354910 · 2022-11-10 ·

A composition comprising a mixture comprising or, alternatively, consisting of: at least one bacterial strain selected from a group comprising or, alternatively, consisting of bacterial strains belonging to the species Lactobacillus paracasei, Lactobacillus rhamnosus, Bifidobacterium bifidum and Bifidobacterium animalis subsp. Lactis, and preferably, at least one extract of at least one species of berries comprising a polyphenol fraction of said berries. and a related method wherein the composition is an immunomodulatory and anti-inflammatory agent are described.

TREATMENT FOR GASTROINTESTINAL DISORDERS
20220354855 · 2022-11-10 ·

Materials and methods for treating irritable bowel syndrome (IBS) are provided herein. For example, materials and methods for increasing the level of hypoxanthine in a mammal identified as having IBS are provided herein

USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH

The disclosure relates to a mixture of bacteria belonging to at least six or seven different and specific bacterial species preferably for use in preventing or treating gastro-intestinal disorders. Preferably, the mixture of bacteria is grown together in a fermenter prior to administering the mixture to a subject in order to prevent or treat the disorder.